As the prevalence of chronic wounds continues to rise, so does the demand for specialized wound care. Conditions such as ...

“Chronic wounds such as diabetic foot ulcers have the pathophysiology ... other types of wounds such as burns, bedsores, venous leg ulcers and even surgical wounds.” The company plans to ...

Celularity (CELU) welcomes action by the Centers for Medicare & Medicaid Services, or CMS, to revise to January 1, 2026, the effective date ...

Although there is wide variation in the cause, location, and characteristics of chronic wounds, collectively, chronic wounds ...

Medical products group Convatec has said the sales outlook for InnovaMatrix has improved after an announcement by the US ...

Action delays to January 1, 2026, the effective date of a Biden-era Medicare LCD for skin substitute products used to treat diabetic foot ulcers and venous leg ulcersFLORHAM PARK, N.J., April 14, 2025 ...

Company reports record preliminary fourth quarter net revenue of $102.9 Million, contributing to a total of $301.8 Million in revenue for ...

As part of the transition to the new administration, CMS is reviewing its coverage policies for skin substitute products.

The advanced wound care market was valued at $9,255.70 million in 2019, and is estimated to reach at $15,305.94 million by 2027, registering a CAGR of 11.6% from 2020 to 2027. Significant increase in ...

Medical products group Convatec shot to the top of the FTSE 100 as it said the sales outlook for InnovaMatrix has improved ...

Shares in ConvaTec opened up 3.2% at 255.40 pence in London on Monday. On Friday, the US Centers for Medicare & Medicaid Services postponed Local Coverage Determinations for skin substitute ...

With the proposed LCDs not finalized, current MAC-specific coverage policies will remain in place through 2025. This includes broad coverage under the Novitas and FCSO LCDs for products with ...